What The Study Did: This survey study looked at how common is the use of marijuana in e-cigarettes among students in grades 6 to 12 and also changes in use by racial and ethnic groups from 2017 to 2020.
What The Study Did: Researchers investigated racial/ethnic representation in clinical trials that led to U.S. Food and Drug Administration approval of ophthalmology drugs from 2000 to 2020.
What The Study Did: Claims data were used to look at opioid use among young people (ages 10 to 21) who had been prescribed opioids for the first time.
Babies born to mothers diagnosed with cannabis use disorder are more likely to experience negative health outcomes, such as preterm birth and low birth weight, than babies born to mothers without a cannabis use disorder diagnosis, report UC San Diego researchers.
A new study of nearly five million live births recorded in California from 2001 to 2012 found that babies born to mothers diagnosed with cannabis use disorders at delivery were more likely to experience negative health outcomes, including preterm birth and low birth weight, compared to babies born to mothers without a cannabis use disorder diagnosis.
People who regularly use psychoactive substances report experiencing a variety of negative impacts since the COVID-19 pandemic began, including increased usage and fear of relapse or overdose, highlighting the need for improved supports and services, including better access to safe supply programs, according to a new CAMH survey published in the International Journal of Drug Policy.
A study published this week in The Lancet Public Health examines how we can use our income assistance systems to address drug use and drug-related harm.
What The Study Did: Data from the Ohio Department of Health were used to evaluate changes in drug overdose mortality in that state by type of drug and age of the user during the first seven months of the COVID-19 epidemic.
Some medical cannabis producers claim that their products contain THC, the metabolite that causes a "high." Other products are advertised as only containing CBD, which does not cause intoxication. This new study finds that producers' claims are sometimes inaccurate, leaving patients at risk of ingesting THC without meaning to, of getting no CBD at all from CBD-labeled products, or of getting no THC from THC-labeled products.
Using an innovative protein-based approach, VA researchers and their academic colleagues have found genes and corresponding proteins that could point the way to new depression treatments.